NCT07283185 Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis
| NCT ID | NCT07283185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asian Institute of Gastroenterology, India |
| Condition | Choledocholithiasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-12-01 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Intermediate likelihood of CBD stone (per ESGE) * Undergoing either MRCP or EUS for evaluation Exclusion Criteria: * High or low likelihood category (per ESGE) * Undergoing both MRCP and EUS simultaneously * Contraindications to either modality
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07283185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Choledocholithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07283185 currently recruiting?
Yes, NCT07283185 is actively recruiting participants. Contact the research team at dr.hardikr@aighospitals.com for enrollment information.
Where is the NCT07283185 trial being conducted?
This trial is being conducted at Hyderabad, India.
Who is sponsoring the NCT07283185 clinical trial?
NCT07283185 is sponsored by Asian Institute of Gastroenterology, India. The trial plans to enroll 200 participants.